“Dr. Schreuder Goedheijt has excellent experience and leadership skills, and he is dedicated to providing the best service and capabilities in our industry,” said Stephan Kutzer, the companies’ CEO. “Dr. Schreuder Goedheijt assumed the role of site leader for the Cambridge Major Laboratories-Europe site in Weert, Netherlands, as part of a comprehensive succession plan that has been in process since Dr. Schreuder Goedheijt joined the CML organization last year. In this role, Marcel is responsible for directing the day-to-day business activities as a leading global service-based chemistry outsourcing partner to the pharmaceutical and biotechnology industries – producing pharmaceutical intermediates, APIs and other fine organic chemicals.”
With more than 15 years of experience in the chemical and pharmaceutical industries, Dr. Schreuder Goedheijt has held leadership positions at DSM Pharma Chemicals, MSD (Organon) and Diosynth. He holds a Ph.D. from Free University Amsterdam and a M.B.A. from Stichting Leergang Bedrijfskunde Arnhem, Netherlands.
Dr. Schreuder Goedheijt remarked, “I am very happy to be part of a leading, growing team at this exciting time and look forward to helping provide exemplary pharmaceutical manufacturing services.”
AAIPharma Services and Cambridge Major Laboratories are General Members of the Pharma & Biopharma Outsourcing Association. Visit our Benefits page to learn more about the PBOA.